nanoparticle albumin bound
Showing 1 - 25 of 2,462
Histological or Cytological Confirmed Stage ? and ?a Thymoma Trial in Shanghai (NAB-Paclitaxel plus Cisplatin, Cisplatin plus
Not yet recruiting
- Histological or Cytological Confirmed Stage Ⅲ and Ⅳa Thymoma
- NAB-Paclitaxel plus Cisplatin
- Cisplatin plus Epirubicin plus Cyclophosphamide
-
Shanghai, Shanghai, ChinaYian Zhang
Apr 17, 2023
Advanced Soft Tissue Sarcoma, Locally Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma Trial in Seattle
Recruiting
- Advanced Soft Tissue Sarcoma
- +2 more
- Nanoparticle Albumin-Bound Rapamycin
- Pazopanib hydrochloride
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 16, 2022
Breast Cancer Trial in Duarte, Pasadena (drug, other, procedure)
Active, not recruiting
- Breast Cancer
- paclitaxel albumin-stabilized nanoparticle formulation
- +6 more
-
Duarte, California
- +1 more
Jan 31, 2023
Locally Advanced Breast Carcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma Trial in United States (Laboratory
Active, not recruiting
- Locally Advanced Breast Carcinoma
- +7 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, California
- +3 more
Jan 31, 2023
Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8 Trial (drug, procedure,
Not yet recruiting
- Advanced Lung Non-Small Cell Carcinoma
- +3 more
- Carboplatin
- +9 more
- (no location specified)
Oct 21, 2023
Childhood Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan
Active, not recruiting
- Childhood Solid Neoplasm
- +4 more
- Irinotecan Hydrochloride
- +4 more
-
Birmingham, Alabama
- +20 more
Feb 1, 2023
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Withdrawn
- Anatomic Stage III Breast Cancer AJCC v8
- +11 more
- Atezolizumab
- +2 more
- (no location specified)
Jan 5, 2023
Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 Trial
Recruiting
- Borderline Resectable Pancreatic Adenocarcinoma
- +5 more
- Durvalumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Triple-Negative Breast
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +4 more
- BET Bromodomain Inhibitor ZEN-3694
- +3 more
- (no location specified)
Jun 28, 2022
Distal Bile Duct Adenocarcinoma, Gallbladder Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Duarte (Cisplatin, Gemcitabine,
Suspended
- Distal Bile Duct Adenocarcinoma
- +7 more
- Cisplatin
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Atlanta
Recruiting
- Advanced Pancreatic Adenocarcinoma
- +2 more
- Gemcitabine
- +3 more
-
Atlanta, Georgia
- +2 more
Feb 28, 2022
Metastatic Pancreatic Ductal Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 Trial
Not yet recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
- +3 more
- Biopsy
- +8 more
- (no location specified)
Jan 13, 2023
Unresectable Locally Advanced or Metastatic Pancreatic Cancer Trial in Shanghai (surufatinib, KN046, gemcitabine)
Not yet recruiting
- Unresectable Locally Advanced or Metastatic Pancreatic Cancer
- surufatinib
- +3 more
-
Shanghai, Shanghai, ChinaZhongshan Hospital
Apr 16, 2023
Solid Tumors Trial in United States (CORT125134 with nab-paclitaxel)
Completed
- Solid Tumors
- Relacorilant with nab-paclitaxel
-
Scottsdale, Arizona
- +3 more
Nov 9, 2022
Resectable Pancreatic Carcinoma, Stage I Pancreatic Cancer AJCC v6 and v7, Stage IA Pancreatic Cancer AJCC v6 and v7 Trial in
Active, not recruiting
- Resectable Pancreatic Carcinoma
- +6 more
- Gemcitabine Hydrochloride
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Aug 16, 2022
Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Trial in
Completed
- Borderline Resectable Pancreatic Adenocarcinoma
- +6 more
- Capecitabine
- +4 more
-
Houston, Texas
- +4 more
Aug 31, 2022
Resectable Intrahepatic Cholangiocarcinoma, Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8, Stage I Intrahepatic
Not yet recruiting
- Resectable Intrahepatic Cholangiocarcinoma
- +4 more
- Cisplatin
- +3 more
-
Atlanta, Georgia
- +2 more
Aug 19, 2022
Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Nashville (procedure, drug, other, biological, radiation)
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- Stage IV Lung Cancer AJCC v8
- Biospecimen Collection
- +9 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Aug 11, 2022
Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8, Unresectable Pancreatic Carcinoma Trial in Duarte
Recruiting
- Stage III Pancreatic Cancer AJCC v8
- +2 more
- Bosentan
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 9, 2021
Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- +15 more
- Cisplatin
- +6 more
-
Los Angeles, California
- +1 more
Aug 5, 2022
HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IIA Breast Cancer Trial in Duarte, Lancaster, South Pasadena
Active, not recruiting
- HER2-positive Breast Cancer
- +9 more
- pertuzumab
- +3 more
-
Duarte, California
- +2 more
Mar 17, 2022
Stage III Intrahepatic Cholangiocarcinoma AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7, Stage IIIB Gallbladder Cancer AJCC v7
Completed
- Stage III Intrahepatic Cholangiocarcinoma AJCC v7
- +8 more
- Cisplatin
- +3 more
-
Scottsdale, Arizona
- +2 more
Jan 5, 2022
Metastatic Breast Cancer Trial in Shanghai (Sitravatinib, Tislelizumab, Nab-paclitaxel)
Recruiting
- Metastatic Breast Cancer
- Sitravatinib
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer
Jul 31, 2022
High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma Trial in Fullerton, Newport Beach, Santa Monica (ABI-009,
Active, not recruiting
- High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma
- ABI-009
- +5 more
-
Fullerton, California
- +2 more
Jun 13, 2022